Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | KDM1A | O60341 | 11/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16242453 | 1.00 | HDAC1 (0.55) | HDAC1HDAC6KDM1AALDH1A1RECQL | |
| SCHEMBL8281129 | 0.84 | KDM1A (0.50) | HDAC1HDAC6KDM1ARECQLLMNA | |
| SCHEMBL14738905 | 0.84 | KDM1A (0.50) | HDAC1HDAC6KDM1ARECQLLMNA | |
| SCHEMBL640673 | 0.83 | CES2 (0.50) | KDM1ARECQLLMNAGFERKMT2A | |
| SCHEMBL640674 | 0.83 | CES2 (0.50) | KDM1ARECQLLMNAGFERKMT2A | |
| SCHEMBL20580081 | 0.80 | KDM1A (0.68) | KDM1ARECQLLMNA | |
| SCHEMBL2772394 | 0.80 | KDM1A (0.68) | KDM1ARECQLLMNA | |
| SCHEMBL25384548 | 0.78 | KDM1A (0.45) | HDAC1HDAC6KDM1ARECQLLMNA | |
| SCHEMBL22394821 | 0.78 | KDM1A (0.45) | KDM1ARECQLLMNAGFERKMT2A | |
| SCHEMBL20244317 | 0.78 | KDM1A (0.45) | HDAC1HDAC6KDM1ARECQLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200138028-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-05-07 | — | — | US | disclosed |
| US-20190284148-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2019-09-19 | — | — | US | disclosed |
| WO-2018015449-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-01-25 | — | — | WO | disclosed |
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| EP-3009433-B1 | 2-PHENYL-1,3-OXAZOLE AND 5-PHENYL-1,2,4-OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES | DAIICHI SANKYO CO LTD (JP) | 2017-06-21 | — | — | EP | disclosed |
| EP-2805941-B1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-3009433-A1 | 2-PHENYL-1,3-OXAZOLE AND 5-PHENYL-1,2,4-OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES | Daiichi Sankyo Company, Limited (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-31 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-2805941-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284148-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | PRF1, ARG1, NOX1 | HDAC1 581/4885HDAC6 736/4885KDM1A 882/4885 |
| US-20200138028-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | PRF1, NOX1, ARG1 | HDAC1 551/4885HDAC6 610/4885KDM1A 850/4885 |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | IAPP, SLC5A1, GPR119 | HDAC1 99/4885HDAC6 352/4885KDM1A 1008/4885 |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | IAPP, SLC5A1, GPR119 | HDAC1 99/4885HDAC6 352/4885KDM1A 1008/4885 |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | IAPP, SLC5A1, GPR119 | HDAC1 109/4885HDAC6 371/4885KDM1A 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.